ChromaDex Newsroom

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $8

Futu NewsNov 6 21:37

ChromaDex Analyst Ratings

BenzingaNov 4 19:52

H.C. Wainwright Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $8

Futu NewsNov 4 19:31

ChromaDex's Robust Q3 Performance and Strategic Initiatives Drive 'Buy' Rating With Raised Price Target

TipRanksNov 4 19:29

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $6

Futu NewsOct 22 21:31

Analysts Are Bullish on Top Healthcare Stocks: Chromadex (CDXC), Anika Therapeutics (ANIK)

TipRanksOct 22 21:27

ChromaDex Analyst Ratings

BenzingaAug 10 05:32

Buy Rating Affirmed on Chromadex's Turnaround and Growth Prospects

TipRanksAug 9 20:14

Roth MKM Remains a Buy on Chromadex (CDXC)

TipRanksAug 8 21:44

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $6

Futu NewsJul 29 20:31

Analysts' Top Healthcare Picks: Chromadex (CDXC), Tarsus Pharmaceuticals (TARS)

TipRanksJul 29 20:06

ChromaDex Analyst Ratings

BenzingaJul 15 18:40

Buy Rating Affirmed for Chromadex on Niagen+ Launch and Market Potential

TipRanksJul 15 18:19

ChromaDex Analyst Ratings

BenzingaJun 12 23:50

Roth MKM Maintains Buy on ChromaDex, Maintains $6 Price Target

BenzingaJun 12 23:46

ChromaDex Analyst Ratings

BenzingaMay 9 19:26

HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target

BenzingaMay 9 19:25

Chromadex Poised for Continued Growth; Selvaraju Reiterates Buy Rating With $6 Target

TipRanksMay 9 18:48

Roth MKM: Maintains ChromaDEX (CDXC.US) rating, adjusted from buy to buy rating, and adjusted target price from $4.25 to $6.00.

Zhitong FinanceApr 9 22:02

ChromaDex Analyst Ratings

BenzingaApr 9 22:00